• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Halo 文库:一种利用晶体筛选片段技术快速鉴定蛋白质配体结合位点的工具。

Halo Library, a Tool for Rapid Identification of Ligand Binding Sites on Proteins Using Crystallographic Fragment Screening.

机构信息

Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, New Jersey 08854, United States.

Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854, United States.

出版信息

J Med Chem. 2023 May 11;66(9):6013-6024. doi: 10.1021/acs.jmedchem.2c01681. Epub 2023 Apr 28.

DOI:10.1021/acs.jmedchem.2c01681
PMID:37115705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10184123/
Abstract

X-ray crystallographic fragment screening (XCFS) uses fragment-sized molecules (∼60 to 300 Da) to access binding sites on proteins that may be inaccessible to larger drug-like molecules (>300 Da). Previous studies have shown that fragments containing halogen atoms bind more often to proteins than non-halogenated fragments. Here, we designed the Halo Library containing 46 halogenated fragments (including the "universal fragment" 4-bromopyrazole), a majority of which have been reported to bind to or inhibit one or more targets. The library was screened against the crystals of HIV-1 reverse transcriptase with the drug rilpivirine, yielding an overall hit rate of 26%. Two new binding sites were discovered, and several hot spots were identified. This small library may thus provide a convenient tool for rapidly assessing the feasibility of a target for XCFS, mapping hot spots and cryptic sites, as well as finding fragment binders that can be useful for developing drug leads.

摘要

X 射线晶体学片段筛选 (XCFS) 使用片段大小的分子(约 60 至 300 道尔顿)来访问蛋白质上可能无法被较大的类药物分子(>300 道尔顿)访问的结合位点。先前的研究表明,含有卤素原子的片段比非卤化片段更频繁地与蛋白质结合。在这里,我们设计了包含 46 个卤化片段(包括“通用片段”4-溴吡唑)的 Halo 文库,其中大部分已被报道与一个或多个靶标结合或抑制。该文库与 HIV-1 逆转录酶的晶体一起进行了 rilpivirine 的筛选,总体命中率为 26%。发现了两个新的结合位点,并确定了几个热点。因此,这个小文库可以为快速评估 XCFS 的靶标可行性、绘制热点和隐匿位点以及寻找可用于开发药物先导物的片段结合物提供便利工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/ba2689ece50b/jm2c01681_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/d44bc12e864d/jm2c01681_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/18b43544ebea/jm2c01681_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/c8be82188f06/jm2c01681_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/d2b940bbade0/jm2c01681_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/ba2689ece50b/jm2c01681_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/d44bc12e864d/jm2c01681_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/18b43544ebea/jm2c01681_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/c8be82188f06/jm2c01681_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/d2b940bbade0/jm2c01681_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3982/10184123/ba2689ece50b/jm2c01681_0006.jpg

相似文献

1
Halo Library, a Tool for Rapid Identification of Ligand Binding Sites on Proteins Using Crystallographic Fragment Screening.Halo 文库:一种利用晶体筛选片段技术快速鉴定蛋白质配体结合位点的工具。
J Med Chem. 2023 May 11;66(9):6013-6024. doi: 10.1021/acs.jmedchem.2c01681. Epub 2023 Apr 28.
2
Hot spot analysis for driving the development of hits into leads in fragment-based drug discovery.基于片段的药物发现中推动命中向先导发展的热点分析。
J Chem Inf Model. 2012 Jan 23;52(1):199-209. doi: 10.1021/ci200468p. Epub 2011 Dec 15.
3
Rapid experimental SAD phasing and hot-spot identification with halogenated fragments.用卤化片段进行快速的实验性 SAD 相测定和热点鉴定。
IUCrJ. 2016 Jan 1;3(Pt 1):51-60. doi: 10.1107/S2052252515021259.
4
Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking.Frag4Lead:使用片段引导模板对接对晶体学片段命中进行目录搜索。
Acta Crystallogr D Struct Biol. 2021 Sep 1;77(Pt 9):1168-1182. doi: 10.1107/S2059798321008196. Epub 2021 Aug 23.
5
Predicting the success of fragment screening by X-ray crystallography.通过X射线晶体学预测片段筛选的成功率。
Methods Enzymol. 2011;493:91-114. doi: 10.1016/B978-0-12-381274-2.00004-2.
6
Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.评估登革热病毒解旋酶和甲基转移酶作为基于片段的药物发现的靶标。
Antiviral Res. 2014 Jun;106:61-70. doi: 10.1016/j.antiviral.2014.03.013. Epub 2014 Apr 1.
7
Crystallographic analysis of TPP riboswitch binding by small-molecule ligands discovered through fragment-based drug discovery approaches.通过基于片段的药物发现方法发现的小分子配体与TPP核糖开关结合的晶体学分析。
Methods Enzymol. 2014;549:221-33. doi: 10.1016/B978-0-12-801122-5.00010-6.
8
Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites.大规模晶体学片段筛选加速化合物优化并确定假定的蛋白质-蛋白质相互作用位点。
J Med Chem. 2022 Nov 10;65(21):14630-14641. doi: 10.1021/acs.jmedchem.2c01165. Epub 2022 Oct 19.
9
Fragment screening and HIV therapeutics.片段筛选与艾滋病治疗
Top Curr Chem. 2012;317:181-200. doi: 10.1007/128_2011_232.
10
FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation.FragLites-Minimal,含卤素的片段展示药效团二联体。一种用于药物评价和苗头化合物生成的有效方法。
J Med Chem. 2019 Apr 11;62(7):3741-3752. doi: 10.1021/acs.jmedchem.9b00304. Epub 2019 Mar 26.

引用本文的文献

1
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond.前所未有的碳酸酐酶抑制机制:通过卤键靶向组氨酸64侧链。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400776. doi: 10.1002/ardp.202400776.
2
High-confidence placement of low-occupancy fragments into electron density using the anomalous signal of sulfur and halogen atoms.利用硫和卤素原子的反常信号,将低占据片段高精度地放置到电子密度中。
Acta Crystallogr D Struct Biol. 2024 Jun 1;80(Pt 6):451-463. doi: 10.1107/S2059798324004480. Epub 2024 Jun 5.
3
Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based Approach.

本文引用的文献

1
Escape from planarity in fragment-based drug discovery: A synthetic strategy analysis of synthetic 3D fragment libraries.基于片段的药物发现中的逃离平面性:合成 3D 片段文库的合成策略分析。
Drug Discov Today. 2022 Sep;27(9):2484-2496. doi: 10.1016/j.drudis.2022.05.021. Epub 2022 May 27.
2
The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble.格勒诺布尔欧洲分子生物学实验室 HTX 设施的自动化晶体学管道。
J Vis Exp. 2021 Jun 5(172). doi: 10.3791/62491.
3
Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin.
基于片段的方法靶向 HIV-1 逆转录酶。
Molecules. 2023 Mar 30;28(7):3103. doi: 10.3390/molecules28073103.
在柏林亥姆霍兹中心的晶体筛选工作流程和工具。
J Vis Exp. 2021 Mar 3(169). doi: 10.3791/62208.
4
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies.作为强效 HIV-1 NNRTIs 的 2,4,5-三取代嘧啶类化合物:合理设计、合成、活性评估及晶体结构研究。
J Med Chem. 2021 Apr 8;64(7):4239-4256. doi: 10.1021/acs.jmedchem.1c00268. Epub 2021 Mar 18.
5
Design, synthesis, and evaluation of "dual-site"-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase.设计、合成和评价“双位点”结合的二芳基嘧啶,以靶向 HIV-1 逆转录酶的 NNIBP 和 NNRTI 相邻位点。
Eur J Med Chem. 2021 Feb 5;211:113063. doi: 10.1016/j.ejmech.2020.113063. Epub 2020 Dec 10.
6
FragMAX: the fragment-screening platform at the MAX IV Laboratory.FragMAX:MAX IV 实验室的碎片筛选平台。
Acta Crystallogr D Struct Biol. 2020 Aug 1;76(Pt 8):771-777. doi: 10.1107/S205979832000889X. Epub 2020 Jul 27.
7
Chemical and structural investigation of the paroxetine-human serotonin transporter complex.帕罗西汀-人血清素转运体复合物的化学和结构研究。
Elife. 2020 Jul 3;9:e56427. doi: 10.7554/eLife.56427.
8
Library Design Strategies To Accelerate Fragment-Based Drug Discovery.图书馆设计策略加速基于片段的药物发现。
Chemistry. 2020 Sep 4;26(50):11391-11403. doi: 10.1002/chem.202000584. Epub 2020 Jul 20.
9
Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance.不断发展的 HIV-1 逆转录酶结构、功能、抑制和耐药性的认识。
Curr Opin Struct Biol. 2020 Apr;61:113-123. doi: 10.1016/j.sbi.2019.11.011. Epub 2020 Jan 11.
10
Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies.从具有毫摩尔效力的三维片段出发发现新型亲环素 D 抑制剂。
Bioorg Med Chem Lett. 2019 Dec 1;29(23):126717. doi: 10.1016/j.bmcl.2019.126717. Epub 2019 Oct 16.